Completed
Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg
NCT02952937
- Conditions
- Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +11 more
- Locations
-
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea